UK markets close in 1 hour 2 minutes

Laboratory Corporation of America Holdings (LAB.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
199.00+2.00 (+1.02%)
As of 08:01AM CET. Market open.
Full screen
Previous close197.00
Open199.00
Bid200.00 x 10000
Ask202.00 x 10000
Day's range199.00 - 199.00
52-week range167.72 - 212.00
Volume17
Avg. volume3
Market cap16.986B
Beta (5Y monthly)1.00
PE ratio (TTM)49.75
EPS (TTM)4.00
Earnings date25 Apr 2024
Forward dividend & yield2.64 (1.34%)
Ex-dividend date26 Feb 2024
1y target est334.29
  • PR Newswire

    Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

  • PR Newswire

    Labcorp to Announce First Quarter Financial Results on April 25, 2024

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

  • Zacks

    Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test

    Labcorp's (LH) pTau217 test is a pivotal blood biomarker intended to aid in the diagnosis of Alzheimer's disease.